1.
N Engl J Med
; 388(16): 1529-1532, 2023 Apr 20.
Article
in English
| MEDLINE | ID: covidwho-2301371
Subject(s)
Antineoplastic Agents, Immunological , Immune Checkpoint Inhibitors , Humans , Antineoplastic Agents, Immunological/adverse effects , Antineoplastic Agents, Immunological/therapeutic use , Immune Checkpoint Inhibitors/adverse effects , Immune Checkpoint Inhibitors/therapeutic use , Immunotherapy , Inventions
2.
N Engl J Med
; 386(12): 1176-1179, 2022 03 24.
Article
in English
| MEDLINE | ID: covidwho-1705591
Subject(s)
COVID-19 , Vaccines , COVID-19/prevention & control , COVID-19 Vaccines , Humans , SARS-CoV-2
3.
N Engl J Med
; 386(2): 183-185, 2022 01 13.
Article
in English
| MEDLINE | ID: covidwho-1648809
4.
N Engl J Med
; 386(4): 394-396, 2022 Jan 27.
Article
in English
| MEDLINE | ID: covidwho-1532206
Subject(s)
Antibodies, Anti-Idiotypic/immunology , Antibodies, Viral/immunology , COVID-19 Vaccines/immunology , COVID-19/immunology , SARS-CoV-2/immunology , Spike Glycoprotein, Coronavirus/immunology , Angiotensin-Converting Enzyme 2/physiology , Animals , Antibodies, Neutralizing/immunology , Disease Models, Animal , Humans , Immunoglobulin Idiotypes/immunology , Mice , Mice, Transgenic , Vaccination
5.
N Engl J Med
; 384(23): e107, 2021 06 10.
Article
in English
| MEDLINE | ID: covidwho-1262029
Subject(s)
COVID-19 Vaccines/adverse effects , Immunoglobulins, Intravenous/therapeutic use , Injections, Intramuscular/adverse effects , Thrombosis/etiology , Anticoagulants/therapeutic use , Autoantibodies/blood , COVID-19 Vaccines/immunology , ChAdOx1 nCoV-19 , Humans , Hypersensitivity , Platelet Factor 4/immunology , Skin/pathology , Thrombocytopenia/etiology , Thrombocytopenia/therapy , Thrombosis/therapy
6.
N Engl J Med
; 384(16): 1564-1565, 2021 04 22.
Article
in English
| MEDLINE | ID: covidwho-1101720
7.
N Engl J Med
; 383(27): 2677-2678, 2020 12 31.
Article
in English
| MEDLINE | ID: covidwho-969054